Literature DB >> 29227752

Systemic Corticosteroid Therapy May Delay Viral Clearance in Patients with Middle East Respiratory Syndrome Coronavirus Infection.

David S Hui1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29227752     DOI： 10.1164/rccm.201712-2371ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  26 in total

Review 1.  The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19.

Authors:  Heloísa Antoniella Braz-de-Melo; Sara Socorro Faria; Gabriel Pasquarelli-do-Nascimento; Igor de Oliveira Santos; Gary P Kobinger; Kelly Grace Magalhães
Journal:  Front Med (Lausanne)       Date:  2021-04-23

2.  COVID-19 and immune checkpoint inhibitors: initial considerations.

Authors:  Ryan J Sullivan; Douglas B Johnson; Brian I Rini; Tomas G Neilan; Christine M Lovly; Javid J Moslehi; Kerry L Reynolds
Journal:  J Immunother Cancer       Date:  2020-05       Impact factor: 13.751

3.  A Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic Era.

Authors:  Jinhee Lee; Han Wul Shin; Jun Young Lee; Jae Seok Kim; Jae Won Yang; Keum Hwa Lee; Andreas Kronbichler; Jae Il Shin
Journal:  Medicina (Kaunas)       Date:  2020-06-26       Impact factor: 2.430

Review 4.  COVID-19 and Cancer: a Comprehensive Review.

Authors:  Rohit Gosain; Yara Abdou; Abhay Singh; Navpreet Rana; Igor Puzanov; Marc S Ernstoff
Journal:  Curr Oncol Rep       Date:  2020-05-08       Impact factor: 5.075

5.  Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region.

Authors:  Monil Majmundar; Tikal Kansara; Joanna Marta Lenik; Hansang Park; Kuldeep Ghosh; Rajkumar Doshi; Palak Shah; Ashish Kumar; Hossam Amin; Shobhana Chaudhari; Imnett Habtes
Journal:  PLoS One       Date:  2020-09-09       Impact factor: 3.240

6.  Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.

Authors:  Tiago Torres; Luis Puig
Journal:  Am J Clin Dermatol       Date:  2020-06       Impact factor: 7.403

Review 7.  Immune-mediated approaches against COVID-19.

Authors:  Helena F Florindo; Ron Kleiner; Daniella Vaskovich-Koubi; Rita C Acúrcio; Barbara Carreira; Eilam Yeini; Galia Tiram; Yulia Liubomirski; Ronit Satchi-Fainaro
Journal:  Nat Nanotechnol       Date:  2020-07-13       Impact factor: 40.523

8.  Scoring systems for predicting mortality for severe patients with COVID-19.

Authors:  Yufeng Shang; Tao Liu; Yongchang Wei; Jingfeng Li; Liang Shao; Minghui Liu; Yongxi Zhang; Zhigang Zhao; Haibo Xu; Zhiyong Peng; Fuling Zhou; Xinghuan Wang
Journal:  EClinicalMedicine       Date:  2020-07-03

Review 9.  Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.

Authors:  Gabriel Pasquarelli-do-Nascimento; Heloísa Antoniella Braz-de-Melo; Sara Socorro Faria; Igor de Oliveira Santos; Gary P Kobinger; Kelly Grace Magalhães
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-28       Impact factor: 5.555

10.  Treatment with convalescent plasma for COVID-19 patients in Wuhan, China.

Authors:  Mingxiang Ye; Dian Fu; Yi Ren; Faxiang Wang; Dong Wang; Fang Zhang; Xinyi Xia; Tangfeng Lv
Journal:  J Med Virol       Date:  2020-06-29       Impact factor: 20.693
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.